Human Pluripotent Stem Cells: Applications and Challenges for Regenerative Medicine and Disease Modeling.

In recent years, human pluripotent stem (hPS) cells have started to emerge as a potential tool with application in fields such as regenerative medicine, disease modeling, and drug screening. In particular, the ability to differentiate human-induced pluripotent stem (hiPS) cells into different cell types and to mimic structures and functions of a specific target organ, resourcing to organoid technology, has introduced novel model systems for disease recapitulation while offering a powerful tool to provide a faster and reproducible approach in the process of drug discovery. All these technologies are expected to improve the overall quality of life of the humankind. Here, we highlight the main applications of hiPS cells and the main challenges associated with the translation of hPS cell derivatives into clinical settings and other biomedical applications, such as the costs of the process and the ability to mimic the complexity of the in vivo systems. Moreover, we focus on the bioprocessing approaches that can be applied towards the production of high numbers of cells as well as their efficient differentiation into the final product and further purification.

[1]  George Church,et al.  Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy , 2015, Science.

[2]  Robert Zweigerdt,et al.  Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. , 2012, Tissue engineering. Part C, Methods.

[3]  Martin J. Aryee,et al.  Epigenetic memory in induced pluripotent stem cells , 2010, Nature.

[4]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[5]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[6]  Tiago G Fernandes,et al.  Towards Multi-Organoid Systems for Drug Screening Applications , 2018, Bioengineering.

[7]  M. Suematsu,et al.  Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. , 2013, Cell stem cell.

[8]  P. Garcez,et al.  Zika virus impairs growth in human neurospheres and brain organoids , 2016, Science.

[9]  Oswald Steward,et al.  Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury , 2005, The Journal of Neuroscience.

[10]  Alex A. Pollen,et al.  Human iPSC-Derived Cerebral Organoids Model Cellular Features of Lissencephaly and Reveal Prolonged Mitosis of Outer Radial Glia. , 2017, Cell stem cell.

[11]  Tiago G Fernandes,et al.  Neural commitment of human pluripotent stem cells under defined conditions recapitulates neural development and generates patient-specific neural cells. , 2015, Biotechnology journal.

[12]  S. Haupt,et al.  A reproducible and versatile system for the dynamic expansion of human pluripotent stem cells in suspension. , 2015, Biotechnology journal.

[13]  E. Sasaki,et al.  Nongenetic method for purifying stem cell–derived cardiomyocytes , 2010, Nature Methods.

[14]  Hideshi Kawakami,et al.  Self-organization of polarized cerebellar tissue in 3D culture of human pluripotent stem cells. , 2015, Cell reports.

[15]  D. Surmeier,et al.  Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD , 2011, Nature.

[16]  Robert Zweigerdt,et al.  Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. , 2010, Stem cell research.

[17]  Ali Khademhosseini,et al.  Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform , 2017, Scientific Reports.

[18]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[19]  Shuying Yang,et al.  Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells , 2010, Stem Cell Reviews and Reports.

[20]  Tara Srinivasan,et al.  Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing , 2017, Nature Medicine.

[21]  Mike J. Mason,et al.  Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. , 2009, Cell stem cell.

[22]  C Maayan,et al.  Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. , 2001, American journal of human genetics.

[23]  John B. Furness,et al.  The enteric nervous system and neurogastroenterology , 2012, Nature Reviews Gastroenterology &Hepatology.

[24]  T. Crawford,et al.  The Neurobiology of Childhood Spinal Muscular Atrophy , 1996, Neurobiology of Disease.

[25]  N. Nakatsuji,et al.  A 3D Sphere Culture System Containing Functional Polymers for Large-Scale Human Pluripotent Stem Cell Production , 2014, Stem cell reports.

[26]  I. Wilmut,et al.  Sheep cloned by nuclear transfer from a cultured cell line , 1996, Nature.

[27]  Marius Wernig,et al.  In vitro differentiation of transplantable neural precursors from human embryonic stem cells , 2001, Nature Biotechnology.

[28]  F. Ginhoux,et al.  Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells , 2017, Stem cell reports.

[29]  Yoshiki Sasai,et al.  Fluorescence‐Activated Cell Sorting–Based Purification of Embryonic Stem Cell–Derived Neural Precursors Averts Tumor Formation after Transplantation , 2006, Stem cells.

[30]  Z. Warren,et al.  Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. , 2014, Morbidity and mortality weekly report. Surveillance summaries.

[31]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[32]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[33]  Thomas Scheper,et al.  Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. , 2010, Stem cell research.

[34]  P. Gutin,et al.  Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. , 2015, Cell stem cell.

[35]  Peter W Zandstra,et al.  Niche‐mediated control of human embryonic stem cell self‐renewal and differentiation , 2007, The EMBO journal.

[36]  Xin Li,et al.  A comparison of non-integrating reprogramming methods , 2014, Nature Biotechnology.

[37]  Amy Cochrane,et al.  Direct reprogramming of adult cells: avoiding the pluripotent state , 2014 .

[38]  Eugenia Kumacheva,et al.  Generation of human embryonic stem cell‐derived mesoderm and cardiac cells using size‐specified aggregates in an oxygen‐controlled bioreactor , 2009, Biotechnology and bioengineering.

[39]  Alan Trounson,et al.  Stem Cell Therapies in Clinical Trials: Progress and Challenges. , 2015, Cell stem cell.

[40]  J. Itskovitz‐Eldor,et al.  Dynamic suspension culture for scalable expansion of undifferentiated human pluripotent stem cells , 2011, Nature Protocols.

[41]  Allan J. Robins,et al.  A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells , 2012, PloS one.

[42]  Maria Margarida Diogo,et al.  Scalable expansion of human-induced pluripotent stem cells in xeno-free microcarriers. , 2015, Methods in molecular biology.

[43]  E. RancourtDerrick,et al.  Factorial Experimental Design for the Culture of Human Embryonic Stem Cells as Aggregates in Stirred Suspension Bioreactors Reveals the Potential for Interaction Effects Between Bioprocess Parameters , 2014 .

[44]  Xiaofang Sun,et al.  Culture in Glucose-Depleted Medium Supplemented with Fatty Acid and 3,3′,5-Triiodo-l-Thyronine Facilitates Purification and Maturation of Human Pluripotent Stem Cell-Derived Cardiomyocytes , 2017, Front. Endocrinol..

[45]  H. Honda,et al.  Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine , 2018, Scientific Reports.

[46]  Joaquim M S Cabral,et al.  Dissolvable Microcarriers Allow Scalable Expansion And Harvesting Of Human Induced Pluripotent Stem Cells Under Xeno-Free Conditions. , 2018, Biotechnology journal.

[47]  Gordana Vunjak-Novakovic,et al.  Advanced maturation of human cardiac tissue grown from pluripotent stem cells , 2018, Nature.

[48]  Takashi Daimon,et al.  Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model , 2012, Circulation.

[49]  A. Viale,et al.  Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs , 2009, Nature.

[50]  Tiago G Fernandes,et al.  Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems , 2016, PloS one.

[51]  Jacob W. Guggenheim,et al.  A process engineering approach to increase organoid yield , 2017, Development.

[52]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[53]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[54]  Karl-Ludwig Laugwitz,et al.  Patient-specific induced pluripotent stem-cell models for long-QT syndrome. , 2010, New England Journal of Medicine.

[55]  H. Young,et al.  Hirschsprung disease: a developmental disorder of the enteric nervous system , 2013, Wiley interdisciplinary reviews. Developmental biology.

[56]  T. Kanazu,et al.  Application of Intestinal Epithelial Cells Differentiated from Human Induced Pluripotent Stem Cells for Studies of Prodrug Hydrolysis and Drug Absorption in the Small Intestine , 2018, Drug Metabolism and Disposition.

[57]  T. Adachi,et al.  Self-organizing optic-cup morphogenesis in three-dimensional culture , 2011, Nature.

[58]  Alain Bel,et al.  Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction. , 2018, Journal of the American College of Cardiology.

[59]  Tiago G Fernandes,et al.  Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture , 2019, Scientific Reports.

[60]  S. Yamanaka,et al.  Induction of pluripotency by defined factors. , 2010, Experimental cell research.

[61]  E. Wirth,et al.  Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury. , 2015, Regenerative medicine.

[62]  Fengtang Yang,et al.  Human blood vessel organoids as a model of diabetic vasculopathy , 2019, Nature.

[63]  Fred H. Gage,et al.  A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.

[64]  J. Bagley,et al.  Fused cerebral organoids model interactions between brain regions , 2017, Nature Methods.

[65]  Hossein Baharvand,et al.  Long-term maintenance of undifferentiated human embryonic and induced pluripotent stem cells in suspension. , 2011, Stem cells and development.

[66]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[67]  M. S. Kallos,et al.  Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. , 2010, Tissue engineering. Part C, Methods.

[68]  L. Ye,et al.  Functional Consequences of Human Induced Pluripotent Stem Cell Therapy: Myocardial ATP Turnover Rate in the In Vivo Swine Heart With Postinfarction Remodeling , 2013, Circulation.

[69]  Philippe Aubert,et al.  Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system , 2016, Nature Medicine.

[70]  Jiannis Ragoussis,et al.  Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels , 2012, Proceedings of the National Academy of Sciences.

[71]  Gail H Deutsch,et al.  In vitro generation of human pluripotent stem cell derived lung organoids , 2015, eLife.

[72]  Joaquim M. S. Cabral,et al.  Scalable culture of human induced pluripotent cells on microcarriers under xeno-free conditions using single-use vertical-wheel™ bioreactors , 2018, Journal of Chemical Technology & Biotechnology.

[73]  A. Björklund,et al.  Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson’s Disease , 2014, Cell stem cell.

[74]  E. Wirth,et al.  Human Embryonic Stem Cell‐Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury , 2017, Stem cells translational medicine.

[75]  T. Fernandes,et al.  Scaling up a chemically‐defined aggregate‐based suspension culture system for neural commitment of human pluripotent stem cells , 2016, Biotechnology journal.

[76]  S. Schwartz,et al.  Embryonic stem cell trials for macular degeneration: a preliminary report , 2012, The Lancet.

[77]  G. Bett,et al.  Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy , 2015, Disease Models & Mechanisms.

[78]  V. Vedantham,et al.  Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.

[79]  Tiago G Fernandes,et al.  A scale out approach towards neural induction of human induced pluripotent stem cells for neurodevelopmental toxicity studies. , 2018, Toxicology letters.

[80]  Kevin Eggan,et al.  Nuclear Reprogramming of Somatic Cells After Fusion with Human Embryonic Stem Cells , 2005, Science.

[81]  Robert Zweigerdt,et al.  Cardiac differentiation of human pluripotent stem cells in scalable suspension culture , 2015, Nature Protocols.

[82]  P. Zandstra,et al.  Reproducible, Ultra High-Throughput Formation of Multicellular Organization from Single Cell Suspension-Derived Human Embryonic Stem Cell Aggregates , 2008, PloS one.

[83]  Hideyuki Okano,et al.  Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity , 2012, PloS one.

[84]  D. Cyranoski ‘Reprogrammed’ stem cells to treat spinal-cord injuries for the first time , 2019, Nature.

[85]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[86]  M. Moorman,et al.  Insulin‐Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo , 2015, Stem cells translational medicine.

[87]  D. Hedges,et al.  Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.

[88]  R. Schwartz,et al.  Scalable Production and Cryostorage of Organoids Using Core–Shell Decoupled Hydrogel Capsules , 2017, Advanced biosystems.

[89]  D. Melton,et al.  Nuclear Reprogramming in Cells , 2008, Science.

[90]  Maria Margarida Diogo,et al.  Separation technologies for stem cell bioprocessing , 2012, Biotechnology and bioengineering.

[91]  S. Lopes,et al.  Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis , 2015, Nature.

[92]  N. Benvenisty,et al.  Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. , 2011, Cell stem cell.

[93]  Cindy Hamil,et al.  Evidence‐based path to newborn screening for duchenne muscular dystrophy , 2012, Annals of neurology.

[94]  H. Onoe,et al.  MHC matching improves engraftment of iPSC-derived neurons in non-human primates , 2017, Nature Communications.

[95]  Gang Bao,et al.  Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection , 2014, Proceedings of the National Academy of Sciences.

[96]  Jeffry D. Sander,et al.  CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.

[97]  P. Burridge,et al.  Improved Human Embryonic Stem Cell Embryoid Body Homogeneity and Cardiomyocyte Differentiation from a Novel V‐96 Plate Aggregation System Highlights Interline Variability , 2007, Stem cells.

[98]  Tiago G. Fernandes,et al.  Spatial and temporal control of cell aggregation efficiently directs human pluripotent stem cells towards neural commitment. , 2015, Biotechnology journal.

[99]  J. Cabral,et al.  Long‐term expansion of human induced pluripotent stem cells in a microcarrier‐based dynamic system , 2017 .

[100]  M. Sittinger,et al.  Effect of inoculum density on human‐induced pluripotent stem cell expansion in 3D bioreactors , 2019, Cell proliferation.

[101]  Jeffrey M Karp,et al.  Engineering Stem Cell Organoids. , 2016, Cell stem cell.

[102]  Praveen Shukla,et al.  Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells. , 2015, Stem cell research.

[103]  H. Schöler,et al.  Induced pluripotent stem cells at nanoscale. , 2010, Stem cells and development.

[104]  T. Nielsen,et al.  Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1. , 2016, Stem cell research.

[105]  Cátia Bandeiras,et al.  Bringing stem cell-based therapies for type 1 diabetes to the clinic: early insights from bioprocess economics and cost-effectiveness analysis. , 2019, Biotechnology journal.

[106]  Pablo Menendez,et al.  Human Induced Pluripotent Stem Cells Develop Teratoma More Efficiently and Faster Than Human Embryonic Stem Cells Regardless the Site of Injection , 2010, Stem cells.

[107]  James A. Thomson,et al.  Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.

[108]  Hossein Baharvand,et al.  A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells , 2015, Stem cells translational medicine.

[109]  R. Kamm,et al.  Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons , 2018, Science Advances.

[110]  Hong Wang,et al.  Naïve Induced Pluripotent Stem Cells Generated From β‐Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9 , 2016, Stem cells translational medicine.

[111]  A. Trounson,et al.  Cell fusion for reprogramming pluripotency , 2007, Stem Cell Reviews.

[112]  S. Gerecht,et al.  Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. , 2013, Stem cell research.

[113]  Donghui Jing,et al.  Cardiac Cell Generation from Encapsulated Embryonic Stem Cells in Static and Scalable Culture Systems , 2010, Cell transplantation.

[114]  Juergen A. Knoblich,et al.  Organogenesis in a dish: Modeling development and disease using organoid technologies , 2014, Science.

[115]  H. Okochi,et al.  Induction of functional islet-like cells from human iPS cells by suspension culture , 2019, Regenerative therapy.

[116]  Nuala Trainor,et al.  Rethinking clinical delivery of adult stem cell therapies , 2014, Nature Biotechnology.

[117]  Satoshi Morita,et al.  Human iPS cell-derived dopaminergic neurons function in a primate Parkinson’s disease model , 2017, Nature.

[118]  H. Baharvand,et al.  Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. , 2012, Tissue engineering. Part C, Methods.

[119]  M. Ohkura,et al.  Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts , 2016, Nature.

[120]  H. Clevers,et al.  Intestinal epithelial organoids fuse to form self-organizing tubes in floating collagen gels , 2017, Development.

[121]  Robert Zweigerdt,et al.  Scalable expansion of human pluripotent stem cells in suspension culture , 2011, Nature Protocols.

[122]  Rudolf Jaenisch,et al.  Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors , 2009, Cell.

[123]  M. Gerstein,et al.  FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders , 2015, Cell.

[124]  D. Kaufman,et al.  Improved development of human embryonic stem cell‐derived embryoid bodies by stirred vessel cultivation , 2006, Biotechnology and bioengineering.

[125]  Vincent C. Chen,et al.  Scalable GMP compliant suspension culture system for human ES cells. , 2012, Stem cell research.

[126]  P. Sullivan,et al.  Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.

[127]  Robert Lanza,et al.  EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Long-Term Safety and Function of RPE from Human Embryonic Stem Cells in Preclinical Models of Macular Degeneration , 2009 .

[128]  F. Yi,et al.  CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs , 2017, Protein & Cell.

[129]  O. Klein,et al.  Transcriptome-wide Analysis Reveals Hallmarks of Human Intestine Development and Maturation In Vitro and In Vivo , 2015, Stem cell reports.

[130]  E. Kroon,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[131]  J. Itskovitz‐Eldor,et al.  Suspension Culture of Undifferentiated Human Embryonic and Induced Pluripotent Stem Cells , 2010, Stem Cell Reviews and Reports.

[132]  M. Fussenegger,et al.  The Growth Factor Inhibitor Suramin Reduces Apoptosis and Cell Aggregation in Protein‐Free CHO Cell Batch Cultures , 2000, Biotechnology progress.

[133]  T. McDevitt,et al.  Rotary Suspension Culture Enhances the Efficiency, Yield, and Homogeneity of Embryoid Body Differentiation , 2007, Stem cells.

[134]  Robert Zweigerdt,et al.  Controlling Expansion and Cardiomyogenic Differentiation of Human Pluripotent Stem Cells in Scalable Suspension Culture , 2014, Stem cell reports.

[135]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[136]  Chad A. Cowan,et al.  A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. , 2010, The Journal of clinical investigation.

[137]  A. Bradley,et al.  Repair of double-strand breaks induced by CRISPR–Cas9 leads to large deletions and complex rearrangements , 2018, Nature Biotechnology.

[138]  Robert Zweigerdt,et al.  Large scale production of stem cells and their derivatives. , 2009, Advances in biochemical engineering/biotechnology.

[139]  Thomas Vierbuchen,et al.  Direct conversion of fibroblasts to functional neurons by defined factors , 2010, Nature.

[140]  Qisheng Zhang,et al.  High-Content Screening in hPSC-Neural Progenitors Identifies Drug Candidates that Inhibit Zika Virus Infection in Fetal-like Organoids and Adult Brain. , 2017, Cell stem cell.

[141]  Madeline A. Lancaster,et al.  Cerebral organoids model human brain development and microcephaly , 2013, Nature.

[142]  Tiago G Fernandes,et al.  Clinical‐scale purification of pluripotent stem cell derivatives for cell‐based therapies , 2015, Biotechnology journal.

[143]  Todd C McDevitt,et al.  The multiparametric effects of hydrodynamic environments on stem cell culture. , 2011, Tissue engineering. Part B, Reviews.

[144]  Alain Bel,et al.  Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. , 2015, European heart journal.

[145]  Robert Zweigerdt,et al.  Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single‐Use Stirred Tank Bioreactors , 2016, Stem cells translational medicine.

[146]  Fred H. Gage,et al.  Modelling schizophrenia using human induced pluripotent stem cells , 2011, Nature.

[147]  A. Gentles,et al.  Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease. , 2017, Cell stem cell.

[148]  P. Itsykson,et al.  Derivation, propagation and controlled differentiation of human embryonic stem cells in suspension , 2010, Nature Biotechnology.

[149]  T. Karlsen,et al.  Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation , 2015, Nature Biotechnology.

[150]  Martin Fussenegger,et al.  Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. , 2003, Biotechnology and bioengineering.

[151]  G. Warnock,et al.  Maturation of Human Embryonic Stem Cell–Derived Pancreatic Progenitors Into Functional Islets Capable of Treating Pre-existing Diabetes in Mice , 2012, Diabetes.

[152]  Alexander Meissner,et al.  Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.

[153]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[154]  Peter W Zandstra,et al.  Chemically controlled aggregation of pluripotent stem cells , 2018, Biotechnology and bioengineering.

[155]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[156]  D. Kotton,et al.  Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling. , 2017, Cell stem cell.

[157]  Z. Ou,et al.  Microdeletions including YWHAE in the Miller–Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment , 2009, Journal of Medical Genetics.

[158]  Shuichi Takayama,et al.  High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. , 2011, The Analyst.

[159]  F. Leisch,et al.  Karyotype variation of CHO host cell lines over time in culture characterized by chromosome counting and chromosome painting , 2018, Biotechnology and bioengineering.

[160]  J. Thomson,et al.  Surface antigens of human embryonic stem cells: changes upon differentiation in culture * , 2002, Journal of anatomy.

[161]  I. Saitoh,et al.  Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection , 2014, Cell Death and Differentiation.

[162]  J V Castell,et al.  Human hepatocytes as a tool for studying toxicity and drug metabolism. , 2003, Current drug metabolism.